Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)
See all recalls from Clinical →✅ What Should You Do?
- ⚠️ Stop using this product until you have checked the recall details below.
- Follow the instructions from the issuing agency (see below).
- 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
- 📋 Report a product safety incident to Health Canada
Looking for a safe alternative?
Search Amazon Canada for other →
Hazard / Issue
Product safety
Issued by
Communications and Public Affairs Branch
⚖️ Were You Affected?
If you were injured or suffered a loss due to this recalled product, you may have legal options.
Search for Class Action Lawyers →Consumer Recalls Canada is not a law firm and does not provide legal advice. We may receive a referral fee if you inquire. We are not affiliated with any law firm or legal service.
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime